[What does Harm Reduction in Tobacco Use means to Public Health]
- PMID: 38804329
- PMCID: PMC11575274
[What does Harm Reduction in Tobacco Use means to Public Health]
Abstract
Harm reduction is a classic Public Health concept to refer to the reduction of the negative effect of drug use/abuse with a focus on justice and human rights, but the tobacco industry has been perverting this concept for years and using it as a tool for its own marketing. This publication details what real harm reduction action on tobacco use would be, when it should be implemented, and what pillars it should be based on. Different methods of reducing the harmful effects of tobacco and nicotine have been tried and tested over time, but the results have been poor; therefore, smoking cessation by the various officially recognised methods is recommended as a priority objective, using the tools that are truly supported by science. In contrast, it also explains the strategies developed by the industry to manipulate consumers and make them dependent on products that can eventually kill them: from the development of filtered cigarettes to light cigarettes, and from menthol to flavoured vapes. In all cases, they have falsely led people to believe that they were developing less toxic products when they were not. Nowadays, both light and menthol cigarettes are banned in Spain, filters have not reduced risk but increased the use, and vapes try to replace cigarettes with their attractive flavours and their false legend of healthier products when what they are really doing is maintaining the same addiction by changing the object, encouraging dual use, and attracting younger and younger non-smokers. At the same time, a strategy of dividing the opinion of health professionals has been developed, using medical doctors and researchers with recognised conflicts of interest but who manage to confuse consumers. In conclusion, we consider that, although nicotine releasing devices may be useful elements in some particular cases, they are not recommended at the population level as they can promote onset, prevent cessation, as well as maintaining the addictive capacity. The only nicotine products that are recommended are those of pharmacological use approved for the case and provided they are used as a transitional tool to complete cessation.
La reducción de daños es un concepto clásico de la Salud Pública para referirse a la reducción del impacto negativo del consumo de drogas con un enfoque de justicia y derechos humanos, pero la industria tabacalera lleva años pervirtiendo este concepto y utilizándolo como una herramienta de su propio marketing. La presente publicación detalla qué sería una verdadera acción de reducción de daños en tabaquismo, cuándo debería aplicarse y en qué pilares debería sostenerse. A lo largo del tiempo se han probado distintos métodos de minorar los efectos perjudiciales del tabaco y de la nicotina, si bien los resultados han sido escasos; así pues, se propone como objetivo prioritario la cesación tabáquica por los distintos métodos reconocidos, utilizando como herramientas las verdaderamente amparadas por la Ciencia. En contraste, se explican también las estrategias desarrolladas por la industria para manipular a los consumidores y hacerles dependientes de unos productos que eventualmente pueden acabar con sus vidas: desde el desarrollo de los cigarrillos con filtro a los light, y de los mentolados a los vapers de sabores. En todos los casos han hecho creer falsamente que desarrollaban productos menos tóxicos cuando no era así. Hoy en día, tanto los cigarrillos light como los mentolados están prohibidos en España, los filtros no han conseguido una disminución del riesgo y sí un aumento del consumo, y los vapers intentan sustituir a los cigarrillos con sus aromas atractivos y su falsa leyenda de productos más sanos cuando lo que están haciendo en realidad es mantener la misma adicción cambiando el objeto, fomentando el consumo dual, y atrayendo a consumidores no-fumadores previos cada vez más jóvenes. Paralelamente, se ha desarrollado una estrategia de división de la opinión de los profesionales sanitarios, con médicos e investigadores con reconocidos conflictos de interés pero que logran confundir al consumidor. Como conclusión consideramos que, si bien en algún caso particular los DSLN (dispositivos susceptibles de liberar nicotina) puedan ser elementos útiles, no son recomendables a nivel poblacional ya que pueden promover el inicio del consumo e impedir la cesación, además de mantener la capacidad adictógena. Los únicos productos de nicotina que se recomiendan son aquellos de uso farmacológico aprobados para el caso y siempre que se usen como herramienta transitoria para la cesación completa.
Keywords: Cessation; Cigarettes; Conflict of interest; Harm reduction; Nicotine releasing devices.; Public Health; Spain; Strategies; Tobacco industry; Vapes.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures
Similar articles
-
European Union policy on smokeless tobacco: a statement in favour of evidence based regulation for public health.Tob Control. 2003 Dec;12(4):360-7. doi: 10.1136/tc.12.4.360. Tob Control. 2003. PMID: 14660767 Free PMC article.
-
No sisyphean task: how the FDA can regulate electronic cigarettes.Yale J Health Policy Law Ethics. 2013 Summer;13(2):326-74. Yale J Health Policy Law Ethics. 2013. PMID: 24340824
-
Obsolete tobacco control themes can be hazardous to public health: the need for updating views on absolute product risks and harm reduction.BMC Public Health. 2016 May 24;16:432. doi: 10.1186/s12889-016-3079-9. BMC Public Health. 2016. PMID: 27221096 Free PMC article.
-
Tobacco harm reduction: the need for new products that can compete with cigarettes.Addict Behav. 2014 Mar;39(3):507-11. doi: 10.1016/j.addbeh.2013.11.002. Epub 2013 Nov 10. Addict Behav. 2014. PMID: 24290207 Review.
-
Effect of smokeless tobacco product marketing and use on population harm from tobacco use policy perspective for tobacco-risk reduction.Am J Prev Med. 2007 Dec;33(6 Suppl):S379-86. doi: 10.1016/j.amepre.2007.09.015. Am J Prev Med. 2007. PMID: 18021913 Review.
References
-
- NIDA. 2023, Febrero 3. ¿Dónde puedo hallar más información sobre el tabaco y la nicotina? Disponible en: https://nida.nih.gov/es/publicaciones/serie-de-reportes/adiccion-al-taba.... 2023, May 12
- NIDA 2023 https://nida.nih.gov/es/publicaciones/serie-de-reportes/adiccion-al-taba... .
-
- Convenio Marco de la OMS para el Control del Tabaco. Organización Mundial de la Salud 2003. https://fctc.who.int/es/publications/9241591013 - PubMed
- Organización Mundial de la Salud; 2003. https://fctc.who.int/es/publications/9241591013 .
-
- Ashton JR, Seymour H. Public health and the origins of the Mersey Model of harm reduction. International Journal of Drug Policy 2010;21:94-96. doi: https://dx.doi.org/10.1016/j.drugpo.2010.01.004 - PubMed
- Ashton JR, Seymour H. Public health and the origins of the Mersey Model of harm reduction. International Journal of Drug Policy. 2010;21:94–96. doi: 10.1016/j.drugpo.2010.01.004. - DOI - PubMed
-
- Russell MA. Low-tar medium-nicotine cigarettes: A new approach to safer smoking. BMJ 1976;1:1430-1433. doi: https://dx.doi.org/10.1136/bmj.1.6023.1430 - PMC - PubMed
- Russell MA. Low-tar medium-nicotine cigarettes: A new approach to safer smoking. BMJ. 1976;1:1430–1433. doi: 10.1136/bmj.1.6023.1430. - DOI - PMC - PubMed
-
- Hatsukami DK, Carroll DM. Tobacco harm reduction: Past history, current controversies and a proposed approach for the future. Preventive Medicine 2020;140:106099. doi: https://dx.doi.org/10.1016/j.ypmed.2020.106099 - PMC - PubMed
- Hatsukami DK, Carroll DM. Tobacco harm reduction: Past history, current controversies and a proposed approach for the future. Preventive Medicine. 2020;140 doi: 10.1016/j.ypmed.2020.106099. - DOI - PMC - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources